|
|
|
Volumn , Issue 66, 2005, Pages 1-4
|
|
Alemtuzumab for B-cell chronic lymphocytic leukemia.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CANCER ANTIBODY;
MONOCLONAL ANTIBODY;
ARTICLE;
B CELL LEUKEMIA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG COST;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
INFECTION;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
UNITED STATES;
ANTIBODIES, MONOCLONAL;
ANTIBODIES, NEOPLASM;
CLINICAL TRIALS;
DRUG COSTS;
HUMANS;
INFECTION;
LEUKEMIA, B-CELL, CHRONIC;
RANDOMIZED CONTROLLED TRIALS;
TREATMENT OUTCOME;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 16244368806
PISSN: 14886324
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|
